PM Philip Morris International Inc

Dividend
3.64%
Previous close
$158.10
Est. 12 months change
+20.49%
Projected Price
$190.83

Profitability Metrics

Return on Equity (ROE)
-
Return on Assets (ROA)
16.54%
Return on Invested Capital (ROIC)
29.91%
Weighted Average Cost of Capital (WACC)
6.00%
ROIC - WACC
23.92%
Updated : 2026-04-03 20:47 ET

Valuation Metrics

P/E Ratio
21.76
Forward P/E
18.70
PEG Ratio
2.71
Debt Current Ratio
0.96

Growth & Cash Flow

Gross Margin
67.12%
Operating Margin
38.94%
FCF Margin
26.23%
TTM Revenue Growth
9.44%
Projected 12M EPS Growth
16.37%

Price Change

Price % from 50 SMA
-10.39%
Price % from 200 SMA
-5.34%
6 Months
0.12%
1 Year
1.24%
2 Years
72.18%
Click here to see the list of ETFs containing PM as a top holding :PM ETFs

Analysis

Company Overview

Philip Morris International markets cigarettes and smoke-free nicotine products, including IQOS heated tobacco devices, in international markets outside the United States. Sector: Consumer Staples.

Overview

Philip Morris International Inc (PM) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

From a returns-on-capital standpoint, ROIC is 29.91%, WACC is 6.00%, and the economic spread is 23.92%. On balance, the company is generating returns that comfortably clear their cost of capital, a reliable indicator of competitive durability. Supporting metrics show ROE at N/A and ROA at 16.54%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

The company's current market valuation reflects trailing P/E of 21.76, forward P/E of 18.70, PEG of 2.71. The trailing-to-forward compression is minimal, consistent with a market that sees limited earnings acceleration from current levels. Growth-adjusted valuation is stretched here — the multiple implies either above-consensus growth or a willingness to pay a premium for quality. The aggregate current ratio of 0.96 points to tighter short-term liquidity across the company. Across multiples and liquidity, the company is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

Margins & Cash Generation

On profitability at each income statement layer, gross margin sits at 67.12%, operating margin at 38.94%, and free cash flow margin at 26.23%. Gross margins are well above average, signaling strong production-level economics across the company. At this operating margin level, the company demonstrate a clear ability to scale profitably. Free cash flow conversion is outstanding — the company is generating exceptional cash after capital expenditures. Across gross, operating, and free cash flow layers, profitability quality appears consistently strong for this company.

Growth & Forward Outlook

Looking at what the company are actually delivering versus what analysts are pricing in, TTM revenue growth of 9.44% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 20.70%, where implied upside appears constructive but not aggressive. Revenue growth captures operating momentum, while price targets reflect external expectations that can move with rates, risk appetite, and sector sentiment. Whether current momentum translates into delivered returns will depend on the durability of both top-line trends and the assumptions embedded in analyst targets. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The composite of ROIC spread, valuation, revenue momentum, and analyst expectations delivers a rare alignment of quality and growth that justifies elevated conviction.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.